Clinical Trials Sponsored by Viacor

Total 293 results

Viacor

Completed

Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device (PTOLEMY)

Heart Failure | Mitral Regurgitation

Canada
Viacor

Completed

Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation (PTOLEMY)

Heart Failure | Mitral Regurgitation

Germany
Viacor

Completed

Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation (PTOLEMY)

Heart Failure | Mitral Regurgitation

Germany
Viacor
Duke University; Medifacts International Corporation

Suspended

Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients (PTOLEMY-2)

Heart Failure | Mitral Regurgitation

Belgium, Czech Republic, Germany, Netherlands, Switzerland
Viacor
Duke University; Medifacts International Corporation

Suspended

Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure (PTOLEMY2Canada)

Heart Failure | Mitral Regurgitation

Canada
Piedmont Healthcare
ViraCor Laboratories

Recruiting

Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients

Kidney Transplant; Complications

United States
Vicor Technologies, Inc.

Withdrawn

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events (VITAL)

Tachycardia, Ventricular | Cardiac Sudden Death

United States
Northwestern University
ViraCor Laboratories

Completed

Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

Atopic Dermatitis | Ichthyosis Vulgaris

United States
Viatar LLC

Unknown

Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood

Metastatic Cancer
BiVACOR Inc.

Not yet recruiting

BiVACOR® Total Artificial Heart Early Feasibility Study

Heart Failure | Biventricular Failure
NYU Langone Health
Viracor Eurofins

Not yet recruiting

CMV Immunity Monitoring in Lung Transplant Recipients

Lung Transplant; Complications

United States
Vifor (International) Inc.

Completed

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Healthy

United Kingdom
Vifor (International) Inc.

Active, not recruiting

Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia (CARE-HK)

Heart Failure | Hyperkalemia

Spain, United States, United Kingdom, Italy, Switzerland, Belgium, Austria
Vifor (International) Inc.

Active, not recruiting

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients (ReliefCensus)

Chronic Kidney Disease-associated Pruritus

Germany, Italy, Portugal, Spain, Sweden, Switzerland, United Kingdom
Vifor (International) Inc.

Withdrawn

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients (CKD)

Chronic Kidney Disease-associated Pruritus
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
Vanderbilt University Medical Center
ViraCor Laboratories

Active, not recruiting

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Liver Transplant Infection | Kidney Transplant Infection | CMV | Heart Transplant Infection

United States
AtaCor Medical, Inc.

Recruiting

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

Conduction Defect

Croatia, Czechia
Miracor Medical SA

Recruiting

A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction. (PiCSO-AMI-V)

Inferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction

France, United Kingdom, Latvia, Switzerland, Denmark
Miracor Medical SA

Not yet recruiting

Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance (PiCSO-AMI-IV)

STEMI - ST Elevation Myocardial Infarction | Anterior MI

Germany
AtaCor Medical, Inc.

Completed

Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrythmia

Paraguay
Vicore Pharma AB

Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Tolerance | Safety Issues

Sweden
Vicore Pharma AB

Completed

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Endothelial Dysfunction | Type2diabetes

Sweden
CinCor Pharma, Inc.

Completed

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) (BrigHTN)

Resistant Hypertension

United States
Miracor Medical SA

Withdrawn

A Study to Evaluate the Safety and Efficacy of PiCSO in Anterior STEMI Patients (PiCSO-AMI-II)

Anterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study (STEP IV)

Conduction Defect

Paraguay
AtaCor Medical, Inc.

Completed

AtaCor Subcostal Temporary Extravascular Pacing III Study (STEP III)

Conduction Defect

New Zealand, Paraguay, Czechia
Vicore Pharma AB

Completed

Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (ATTRACT-2)

Covid19

India
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extracardiac Pacing II Study (STEP II)

Conduction Defect

New Zealand, Paraguay
Miracor Medical SA

Completed

PiCSO in ACS Study

Acute Coronary Syndrome

United Kingdom
Visior Technologies Ltd.

Unknown

Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation

Cerebral Arterial Diseases

Israel
Visior Technologies Ltd.

Completed

Assessment of Device for Treatment of Amblyopia

Amblyopia

Israel
Miracor Medical SA

Completed

PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)

ST Elevation (STEMI) Myocardial Infarction

Netherlands
Vifor Pharma, Inc.

Recruiting

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

Hyperkalemia

United States, Israel
Vifor (International) Inc.

Active, not recruiting

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients (PORTRAY)

Chronic Kidney Disease

Germany
Vifor Pharma, Inc.

Terminated

FDDA Utilization Study (FDDAU)

Fatigue

Switzerland
AtaCor Medical, Inc.

Recruiting

Subcostal Temporary Extravascular Pacing V Study (STEP V)

Conduction Defect

Paraguay
Vicore Pharma AB

Completed

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects (ATTRACT-3)

COVID-19

Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
AtaCor Medical, Inc.

Completed

Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study (SECURE EV)

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmia

Paraguay
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extracardiac Pacing Study (STEP)

Conduction Defect

Paraguay
Miracor Medical SA

Completed

Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention (PICSO)

Stable Angina

Netherlands
BIDI Vapor

Completed

BIDI Stick ENDS Abuse Liability and Puffing Topography Assessment

Cigarette Smoking | E-cigarette Use

Poland
Vifor Pharma

Completed

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF)

Chronic Heart Failure | Iron Deficiency

Netherlands
Vifor Pharma

Completed

Study of Phosphate Levels in Patients With Chronic Kidney Disease (PA21)

Chronic Kidney Disease

United States, Switzerland, Romania, Croatia, Bulgaria, Germany, Czech Republic, Poland, Russian Federation
Vifor Pharma

Not yet recruiting

Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment (CARENFERPA)

Iron-deficiency
Vifor Pharma

Terminated

Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy (AOC-MM)

Iron-Deficiency Anemia

France, Greece
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Omeprazole and PA21

Healthy

United States
Michael Ison
ViraCor Laboratories

Completed

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients (ViracorCMI)

Infection in Solid Organ Transplant Recipients | Awaiting Organ Transplant

United States
CinCor Pharma, Inc.

Completed

A Study of CIN-107 in Patients With Uncontrolled Hypertension (HALO)

Uncontrolled Hypertension

United States
Vicore Pharma AB

Completed

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

Drug Interaction

Sweden

Clinical Trials Sponsored by Viacor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations